ANTARES PHARMA INC's ticker is ATRS and the CUSIP is 036642106. A total of 166 filers reported holding ANTARES PHARMA INC in Q3 2020. The put-call ratio across all filers is 1.96 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $1,008,000 | +14.8% | 245,801 | 0.0% | 0.00% | 0.0% |
| Q4 2021 | $878,000 | -1.9% | 245,801 | 0.0% | 0.00% | 0.0% |
| Q3 2021 | $895,000 | -14.8% | 245,801 | +2.1% | 0.00% | -33.3% |
| Q2 2021 | $1,050,000 | +25.3% | 240,801 | +18.2% | 0.00% | +50.0% |
| Q1 2021 | $838,000 | +3.1% | 203,801 | 0.0% | 0.00% | 0.0% |
| Q4 2020 | $813,000 | +48.4% | 203,801 | +0.5% | 0.00% | 0.0% |
| Q3 2020 | $548,000 | +0.2% | 202,801 | +2.0% | 0.00% | 0.0% |
| Q2 2020 | $547,000 | +16.6% | 198,801 | 0.0% | 0.00% | 0.0% |
| Q1 2020 | $469,000 | -41.9% | 198,801 | +15.8% | 0.00% | -33.3% |
| Q4 2019 | $807,000 | +25.7% | 171,740 | -10.5% | 0.00% | 0.0% |
| Q3 2019 | $642,000 | +1.7% | 191,801 | 0.0% | 0.00% | +50.0% |
| Q2 2019 | $631,000 | +8.6% | 191,801 | 0.0% | 0.00% | -33.3% |
| Q1 2019 | $581,000 | +11.3% | 191,801 | 0.0% | 0.00% | -25.0% |
| Q4 2018 | $522,000 | -9.7% | 191,801 | +8.1% | 0.00% | 0.0% |
| Q3 2018 | $578,000 | +24.8% | 177,351 | -1.2% | 0.00% | +33.3% |
| Q2 2018 | $463,000 | +22.8% | 179,511 | +4.8% | 0.00% | 0.0% |
| Q1 2018 | $377,000 | +10.6% | 171,310 | 0.0% | 0.00% | +50.0% |
| Q4 2017 | $341,000 | -44.4% | 171,310 | -9.5% | 0.00% | -60.0% |
| Q3 2017 | $613,000 | -2.5% | 189,310 | -3.1% | 0.01% | 0.0% |
| Q2 2017 | $629,000 | +12.3% | 195,310 | -0.9% | 0.01% | 0.0% |
| Q1 2017 | $560,000 | +20.7% | 197,010 | -1.1% | 0.01% | +25.0% |
| Q4 2016 | $464,000 | +18.7% | 199,211 | -14.3% | 0.00% | 0.0% |
| Q3 2016 | $391,000 | +56.4% | 232,544 | -7.0% | 0.00% | +100.0% |
| Q2 2016 | $250,000 | +14.7% | 250,000 | 0.0% | 0.00% | 0.0% |
| Q1 2016 | $218,000 | -28.1% | 250,000 | 0.0% | 0.00% | -33.3% |
| Q4 2015 | $303,000 | -28.7% | 250,000 | 0.0% | 0.00% | -40.0% |
| Q3 2015 | $425,000 | -22.0% | 250,000 | -4.6% | 0.01% | 0.0% |
| Q2 2015 | $545,000 | – | 262,000 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Healthcare Value Capital, LLC | 500,000 | $2,180,000 | 4.34% |
| FIRST WILSHIRE SECURITIES MANAGEMENT INC | 2,535,727 | $11,056,000 | 3.87% |
| Sargent Investment Group, LLC | 3,596,250 | $15,680,000 | 3.72% |
| Rubric Capital Management LP | 9,500,000 | $41,420,000 | 2.61% |
| PERKINS CAPITAL MANAGEMENT INC | 541,783 | $2,362,000 | 1.34% |
| ORACLE INVESTMENT MANAGEMENT INC | 1,900,000 | $8,284,000 | 1.14% |
| Venator Capital Management Ltd. | 709,700 | $3,094,000 | 1.05% |
| LEVEL FOUR FINANCIAL, LLC | 120,000 | $523,000 | 0.22% |
| OBERWEIS ASSET MANAGEMENT INC/ | 200,600 | $875,000 | 0.19% |
| Brown Advisory Securities, LLC | 275,000 | $1,199,000 | 0.19% |